139 related articles for article (PubMed ID: 32426657)
41. Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
Milling TJ; Spyropoulos AC
Am J Med; 2016 Nov; 129(11S):S54-S63. PubMed ID: 27569671
[TBL] [Abstract][Full Text] [Related]
42. Topical application of tranexamic acid for the reduction of bleeding.
Ker K; Beecher D; Roberts I
Cochrane Database Syst Rev; 2013 Jul; (7):CD010562. PubMed ID: 23881695
[TBL] [Abstract][Full Text] [Related]
43. Reversal agents for oral anticoagulant-associated major or life-threatening bleeding.
Moia M; Squizzato A
Intern Emerg Med; 2019 Nov; 14(8):1233-1239. PubMed ID: 31446606
[TBL] [Abstract][Full Text] [Related]
44. Bleeding complications from the direct oral anticoagulants.
Sholzberg M; Pavenski K; Shehata N; Cserti-Gazdewich C; Lin Y
BMC Hematol; 2015; 15():18. PubMed ID: 26705474
[TBL] [Abstract][Full Text] [Related]
45. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial.
Zhao H; Xiang M; Xia Y; Shi X; Pei FX; Kang P
Int Orthop; 2018 Nov; 42(11):2535-2542. PubMed ID: 29492612
[TBL] [Abstract][Full Text] [Related]
47. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.
Gómez-Outes A; Alcubilla P; Calvo-Rojas G; Terleira-Fernández AI; Suárez-Gea ML; Lecumberri R; Vargas-Castrillón E
J Am Coll Cardiol; 2021 Jun; 77(24):2987-3001. PubMed ID: 34140101
[TBL] [Abstract][Full Text] [Related]
48. Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate.
Sheikh-Taha M
Intern Emerg Med; 2019 Mar; 14(2):265-269. PubMed ID: 30414056
[TBL] [Abstract][Full Text] [Related]
49. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
[TBL] [Abstract][Full Text] [Related]
50. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
51. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients.
Cai J; Ribkoff J; Olson S; Raghunathan V; Al-Samkari H; DeLoughery TG; Shatzel JJ
Eur J Haematol; 2020 Feb; 104(2):79-87. PubMed ID: 31729076
[TBL] [Abstract][Full Text] [Related]
52. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial.
Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B;
J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230
[TBL] [Abstract][Full Text] [Related]
53. Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants.
Müller M; Traschitzger M; Nagler M; Arampatzis S; Exadaktylos AK; Sauter TC
BMC Emerg Med; 2021 Sep; 21(1):105. PubMed ID: 34536992
[TBL] [Abstract][Full Text] [Related]
54. Topical use of tranexamic acid for the management of post-procedural rectal bleeding.
Altawil Z; Gendron BJ; Schechter-Perkins EM
Am J Emerg Med; 2019 Jan; 37(1):173.e3-173.e4. PubMed ID: 30343959
[TBL] [Abstract][Full Text] [Related]
55. Comparison of oral vs. combined topical/intravenous/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: A randomised clinical trial.
King L; Randle R; Dare W; Bernaitis N
Orthop Traumatol Surg Res; 2019 Oct; 105(6):1073-1077. PubMed ID: 31473130
[TBL] [Abstract][Full Text] [Related]
56. What we have learned about direct oral anticoagulant reversal.
Siegal DM
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):198-203. PubMed ID: 31808835
[TBL] [Abstract][Full Text] [Related]
57. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
Lošťák J; Gallo J; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
[TBL] [Abstract][Full Text] [Related]
58. A Case Report of Nebulized Tranexamic Acid for Post-tonsillectomy Hemorrhage in an Adult.
Poppe M; Grimaldo F
Clin Pract Cases Emerg Med; 2020 Aug; 4(3):443-445. PubMed ID: 32926708
[TBL] [Abstract][Full Text] [Related]
59. [Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
Gombár C; Gálity H; Bácsi M; Sisák K
Orv Hetil; 2019 Mar; 160(12):456-463. PubMed ID: 30876382
[TBL] [Abstract][Full Text] [Related]
60. The Use of Tranexamic Acid (TXA) for the Management of Hemorrhage in Trauma Patients in the Prehospital Environment: Literature Review and Descriptive Analysis of Principal Themes.
Stansfield R; Morris D; Jesulola E
Shock; 2020 Mar; 53(3):277-283. PubMed ID: 32044848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
